Suppr超能文献

STRAD 在秀丽隐杆线虫 LKB1 依赖性功能中的差异需求。

Differential requirements for STRAD in LKB1-dependent functions in C. elegans.

机构信息

Department of Biology, McGill University, Québec, Canada.

出版信息

Development. 2010 Feb;137(4):661-70. doi: 10.1242/dev.042044.

Abstract

The protein kinase LKB1 is a crucial regulator of cell growth/proliferation and cell polarity and is the causative gene in the cancer-predisposing disease Peutz-Jeghers syndrome (PJS). The activity of LKB1 is greatly enhanced following its association with the Ste20-like adapter protein STRAD. Unlike LKB1 however, mutations in STRAD have not been identified in PJS patients and thus, the key tumour suppressive role(s) of LKB1 might be STRAD independent. Here, we report that Caenorhabditis elegans strd-1/STRAD mutants recapitulate many phenotypes typical of par-4/LKB1 loss of function, showing defects during early embryonic and dauer development. Interestingly, although the growth/proliferation defects in severe par-4 and strd-1 mutant dauers are comparable, strd-1 mutant embryos do not share the polarity defects of par-4 embryos. We demonstrate that most of par-4-dependent regulation of germline stem cell (GSC) quiescence occurs through AMPK, whereby PAR-4 requires STRD-1 to phosphorylate and activate AMPK. Consistent with this, even though AMPK plays a major role in the regulation of cell proliferation, like strd-1 it does not affect embryonic polarity. Instead, we found that the PAR-4-mediated phosphorylation of polarity regulators such as PAR-1 and MEX-5 in the early embryo occurs in the absence of STRD-1. Thus, PAR-4 requires STRD-1 to phosphorylate AMPK to regulate cell growth/proliferation under reduced insulin signalling conditions, whereas PAR-4 can promote phosphorylation of key proteins, including PAR-1 and MEX-5, to specify early embryonic polarity independently of STRD-1. Our results therefore identify a key strd-1/STRAD-independent function of par-4/LKB1 in polarity establishment that is likely to be important for tumour suppression in humans.

摘要

蛋白激酶 LKB1 是细胞生长/增殖和细胞极性的关键调节因子,也是易患癌症的 Peutz-Jeghers 综合征(PJS)的致病基因。LKB1 的活性在与 Ste20 样接头蛋白 STRAD 结合后大大增强。然而,与 LKB1 不同,PJS 患者中并未发现 STRAD 突变,因此,LKB1 的关键肿瘤抑制作用可能与 STRAD 无关。在这里,我们报告说,秀丽隐杆线虫 strd-1/STRAD 突变体重现了许多典型的 par-4/LKB1 功能丧失的表型,在早期胚胎和 dauer 发育过程中出现缺陷。有趣的是,尽管严重的 par-4 和 strd-1 突变体 dauer 的生长/增殖缺陷相当,但 strd-1 突变体胚胎没有共享 par-4 胚胎的极性缺陷。我们证明,大多数 par-4 依赖的生殖细胞(GSC)静止调节都通过 AMPK 发生,其中 PAR-4 需要 STRD-1 来磷酸化和激活 AMPK。与此一致,尽管 AMPK 在细胞增殖的调节中起着主要作用,但它与 strd-1 一样,不会影响胚胎极性。相反,我们发现,即使在没有 STRD-1 的情况下,PAR-4 也可以在早期胚胎中调节 PAR-1 和 MEX-5 等极性调节剂的磷酸化。因此,PAR-4 需要 STRD-1 来磷酸化 AMPK 以在胰岛素信号降低的情况下调节细胞生长/增殖,而 PAR-4 可以促进包括 PAR-1 和 MEX-5 在内的关键蛋白的磷酸化,从而独立于 STRD-1 来指定早期胚胎极性。因此,我们的研究结果确定了 par-4/LKB1 在建立极性中的一个关键的 strd-1/STRAD 独立功能,这可能对人类肿瘤抑制很重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验